Nina S Kjellson's Net Worth
$443 Million
Who is Nina S Kjellson?
Nina S Kjellson has an estimated net worth of $443 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., EnteroMedics Inc, Invuity, Inc., GLAUKOS Corp, Carbylan Therapeutics, Inc., Trius Therapeutics Inc, Tyra Biosciences, Inc., Panacea Acquisition Corp. II, Eiger BioPharmaceuticals, Inc., Marketo, Inc., Cidara Therapeutics, Inc., Transcept Pharmaceuticals Inc, and Ocera Therapeutics, Inc..
SEC CIK
Nina S Kjellson's CIK is 0001381980
Past Insider Trading and Trends
2014 was Nina S Kjellson's most active year for acquiring shares with 33 total transactions. Nina S Kjellson's most active month to acquire stocks was the month of April. 2014 was Nina S Kjellson's most active year for disposing of shares, totalling 27 transactions. Nina S Kjellson's most active month to dispose stocks was the month of April. 2010 saw Nina S Kjellson paying a total of $9,397,557.48 for 3,560,643 shares, this is the most they've acquired in one year. In 2013 Nina S Kjellson cashed out on 12,490,928 shares for a total of $71,302,471.54, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TESARO, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.53% | -600.00K |
—
|
—
| 2.47M |
Aug 5
| |||
Form 4
|
∞
| 3.07M |
$13.50 |
—
| 3.07M |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Invuity, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.08M |
—
|
—
| 1.08M |
Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLAUKOS Corp (GKOS) Snapshot price: $94.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.6M |
—
|
—
| 2.6M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Carbylan Therapeutics, Inc. (KALV) Snapshot price: $14.5375
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.62M |
$5.00 |
—
| 4.62M |
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Marketo, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -71.64% | -124.48K |
$24.31 | -$3,006,776.01 | 49.27K |
May 29 - May 30
| |||
Form 4
| -17.35% | -848.00K |
—
|
—
| 4.04M |
May 28
| |||
Form 4
| -39.07% | -10.00K |
$24.01 | -$240,090.00 | 15.6K |
May 20 - May 21
| |||
Form 4
| -36.95% | -15.00K |
$22.96 | -$344,427.00 | 25.6K |
May 16
| |||
Form 4
| -100.00% | -34.46K |
$24.27 | -$836,427.15 |
0
|
May 13 - May 14
| |||
Form 4
| -14.63% | -848.00K |
—
|
—
| 4.95M |
May 12
| |||
Form 4
| -61.95% | -24.42K |
$41.96 | -$1,024,605.20 | 15K |
Feb 27 - Feb 28
| |||
Form 4
| -61.55% | -33.05K |
$40.33 | -$1,334,791.50 | 20.65K |
Feb 26
| |||
Form 4
| -18.79% | -1.35M |
—
|
—
| 5.85M |
Feb 25
| |||
Form 4
| -100.00% | -4.35K |
$40.70 | -$177,045.00 |
0
|
Feb 13
| |||
Form 4
| -5.89% | -451.49K |
—
|
—
| 7.21M |
Feb 12
| |||
Form 4
| -21.37% | -2.08M |
$33.99 | -$70,818,664.12 | 7.66M |
Sep 18
| |||
Form 4
|
∞
| 9.75M |
—
|
—
| 9.75M |
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||